The purpose of our study was to determine the frequency of CALR mutations (first cohort of 123 MPN patients) and coexisting CALR and JAK2 mutations (combined cohort subset of 167 ET patients) in Korean patients with BCR-ABL1 rearrangement-negative MPNs. This evidence concerns the gene JAK2 and myeloproliferative disorder.